ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Data as of Apr 16
 +3.17 / +14.66%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

ANI Pharmaceuticals, Inc. is a pharmaceutical company which develops, manufactures and markets prescription pharmaceuticals in the U.S. The company focuses on developing products for female sexual health, menopause, contraception and male hypogonadism. Its products include LibiGel, a transdermal testosterone gel, which is used for the treatment of female sexual dysfunction, specifically hypoactive sexual desire disorder; Testosterone Gel for Men, which is used for the treatment of hypogonadism, or testosterone deficiency in men; The Pill-Plus, which is used for various combinations of estrogens, progestogens and androgens; and Elestrin, a transdermal estradiol gel, which is used for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Contact Information

ANI Pharmaceuticals, Inc.
210 Main Street West
Baudette Minnesota 56623
P:(218) 634-3500
Investor Relations:



Individual stakeholders49.86%
Mutual fund holders3.86%
Other institutional23.95%

Top Executives

Arthur S. PrzybylPresident, Chief Executive Officer & Director
James G. MarkenVice President-Operations
Charlotte C. ArnoldChief Financial Officer, Secretary, Treasurer & VP
Joanne ZborowskiVice President-Clinical Development
Patricia FullerVice President-Information Technology

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.